Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 4 | 2023 | 42 | 2.270 |
Why?
|
| Ischemia | 6 | 2024 | 253 | 1.520 |
Why?
|
| Retina | 3 | 2021 | 220 | 1.310 |
Why?
|
| Lung Injury | 4 | 2023 | 53 | 1.140 |
Why?
|
| Lung | 12 | 2023 | 1292 | 1.040 |
Why?
|
| Retinal Diseases | 3 | 2023 | 90 | 1.040 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2013 | 41 | 0.910 |
Why?
|
| Ischemic Postconditioning | 2 | 2020 | 10 | 0.850 |
Why?
|
| Culture Media, Conditioned | 2 | 2019 | 103 | 0.750 |
Why?
|
| Beclin-1 | 1 | 2020 | 15 | 0.710 |
Why?
|
| Retinal Vessels | 2 | 2018 | 59 | 0.680 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 64 | 0.680 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 61 | 0.670 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 262 | 0.640 |
Why?
|
| Autophagy | 2 | 2020 | 159 | 0.640 |
Why?
|
| Bleomycin | 2 | 2015 | 103 | 0.600 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 100 | 0.600 |
Why?
|
| Sphingosine | 4 | 2013 | 74 | 0.600 |
Why?
|
| MicroRNAs | 1 | 2023 | 556 | 0.590 |
Why?
|
| Lysophospholipids | 3 | 2013 | 66 | 0.580 |
Why?
|
| Glucose | 1 | 2020 | 629 | 0.570 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 29 | 0.570 |
Why?
|
| Radiation Injuries | 2 | 2023 | 161 | 0.520 |
Why?
|
| Rats | 7 | 2023 | 4048 | 0.510 |
Why?
|
| Animals | 26 | 2024 | 27536 | 0.490 |
Why?
|
| Oxygen | 1 | 2020 | 746 | 0.490 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2013 | 2 | 0.440 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 9 | 0.440 |
Why?
|
| Gamma Rays | 1 | 2013 | 73 | 0.440 |
Why?
|
| Sphingolipids | 2 | 2023 | 20 | 0.430 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 43 | 0.430 |
Why?
|
| Retinal Ganglion Cells | 3 | 2024 | 71 | 0.430 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 399 | 0.420 |
Why?
|
| Pulmonary Fibrosis | 4 | 2015 | 138 | 0.410 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2013 | 37 | 0.380 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 24 | 0.370 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 728 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1983 | 0.360 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 45 | 0.360 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 2395 | 0.360 |
Why?
|
| Astrocytes | 2 | 2021 | 142 | 0.340 |
Why?
|
| Simvastatin | 1 | 2010 | 105 | 0.340 |
Why?
|
| Rats, Wistar | 3 | 2020 | 303 | 0.340 |
Why?
|
| Mice | 15 | 2024 | 11858 | 0.320 |
Why?
|
| Intravitreal Injections | 2 | 2021 | 73 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 3253 | 0.320 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 41 | 0.280 |
Why?
|
| Macrophages | 2 | 2007 | 582 | 0.270 |
Why?
|
| Disease Progression | 1 | 2010 | 1469 | 0.260 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 377 | 0.260 |
Why?
|
| Trachea | 1 | 2007 | 292 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 341 | 0.250 |
Why?
|
| Endothelial Cells | 4 | 2023 | 464 | 0.250 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2024 | 346 | 0.240 |
Why?
|
| Capillary Permeability | 5 | 2018 | 132 | 0.240 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 144 | 0.240 |
Why?
|
| Mice, Knockout | 5 | 2013 | 2016 | 0.240 |
Why?
|
| Hypoxia | 2 | 2023 | 657 | 0.240 |
Why?
|
| Epithelial Cells | 2 | 2018 | 689 | 0.230 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2013 | 80 | 0.230 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2013 | 127 | 0.220 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 490 | 0.210 |
Why?
|
| Optic Neuritis | 1 | 2021 | 10 | 0.200 |
Why?
|
| Cell Line | 3 | 2019 | 2495 | 0.190 |
Why?
|
| Neuromyelitis Optica | 1 | 2021 | 22 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1131 | 0.190 |
Why?
|
| Particulate Matter | 2 | 2012 | 102 | 0.190 |
Why?
|
| Retinal Neurons | 1 | 2021 | 11 | 0.190 |
Why?
|
| Fluorescence | 1 | 2021 | 103 | 0.180 |
Why?
|
| Staining and Labeling | 1 | 2021 | 169 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1237 | 0.180 |
Why?
|
| Microglia | 1 | 2021 | 108 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2017 | 122 | 0.170 |
Why?
|
| Electroretinography | 2 | 2017 | 77 | 0.170 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2887 | 0.170 |
Why?
|
| Lysosomes | 1 | 2020 | 113 | 0.160 |
Why?
|
| Cell Death | 1 | 2020 | 261 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2018 | 3404 | 0.160 |
Why?
|
| Cytokines | 1 | 2023 | 811 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 217 | 0.150 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2018 | 33 | 0.150 |
Why?
|
| Sulfones | 1 | 2018 | 45 | 0.150 |
Why?
|
| Kinetics | 1 | 2021 | 1534 | 0.150 |
Why?
|
| Quinolones | 1 | 2018 | 56 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 2370 | 0.150 |
Why?
|
| Blood-Retinal Barrier | 1 | 2017 | 4 | 0.140 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 198 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 99 | 0.140 |
Why?
|
| Eye Proteins | 1 | 2018 | 128 | 0.140 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 37 | 0.130 |
Why?
|
| Radiation | 1 | 2015 | 15 | 0.130 |
Why?
|
| Aldehyde-Lyases | 1 | 2015 | 15 | 0.130 |
Why?
|
| Free Radical Scavengers | 2 | 2012 | 59 | 0.120 |
Why?
|
| Inflammation | 2 | 2024 | 981 | 0.120 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2014 | 4 | 0.120 |
Why?
|
| Acyltransferases | 1 | 2014 | 41 | 0.110 |
Why?
|
| Thiophenes | 2 | 2011 | 43 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 586 | 0.110 |
Why?
|
| Oxadiazoles | 2 | 2011 | 38 | 0.110 |
Why?
|
| Collagen | 1 | 2015 | 294 | 0.110 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 9 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 20 | 0.110 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2014 | 199 | 0.110 |
Why?
|
| Apoptosis | 2 | 2017 | 1718 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2013 | 30 | 0.110 |
Why?
|
| Oxidants | 1 | 2013 | 86 | 0.110 |
Why?
|
| Humans | 13 | 2023 | 90014 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2011 | 340 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 158 | 0.100 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1670 | 0.100 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2012 | 4 | 0.100 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2012 | 12 | 0.100 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.100 |
Why?
|
| Microvessels | 1 | 2012 | 69 | 0.100 |
Why?
|
| Male | 8 | 2020 | 42705 | 0.100 |
Why?
|
| Calpain | 1 | 2012 | 113 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2012 | 52 | 0.100 |
Why?
|
| Ceramides | 1 | 2011 | 35 | 0.090 |
Why?
|
| Air Pollutants | 1 | 2012 | 96 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 50 | 0.090 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 556 | 0.090 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 21 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 38 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 435 | 0.090 |
Why?
|
| Brain Death | 1 | 2011 | 83 | 0.090 |
Why?
|
| Electric Impedance | 3 | 2018 | 111 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 81 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2013 | 1227 | 0.080 |
Why?
|
| Blood-Air Barrier | 1 | 2009 | 6 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 644 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 486 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 569 | 0.080 |
Why?
|
| Female | 6 | 2018 | 46617 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 727 | 0.080 |
Why?
|
| Prostaglandin D2 | 1 | 2007 | 28 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2015 | 326 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 295 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2007 | 36 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 74 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 86 | 0.070 |
Why?
|
| Gene Expression | 2 | 2011 | 1309 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2018 | 1130 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2015 | 726 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 349 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2007 | 426 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1158 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2007 | 443 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2588 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 665 | 0.060 |
Why?
|
| Reperfusion | 1 | 2024 | 32 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 206 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 469 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 66 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2023 | 96 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 9 | 0.050 |
Why?
|
| Pneumonia | 2 | 2013 | 183 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 11 | 0.040 |
Why?
|
| Biomarkers | 2 | 2014 | 1778 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2016 | 5 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 5361 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 241 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 43 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2014 | 17 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 313 | 0.030 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 11 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2013 | 30 | 0.030 |
Why?
|
| Permeability | 1 | 2012 | 138 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 759 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2012 | 71 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 247 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1452 | 0.020 |
Why?
|
| Thorax | 1 | 2012 | 77 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 125 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 33 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 198 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 696 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 511 | 0.020 |
Why?
|
| Drug Inverse Agonism | 1 | 2009 | 3 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 383 | 0.020 |
Why?
|
| Body Fluids | 1 | 2009 | 34 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2018 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 458 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1732 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 329 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1533 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1863 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2026 | 0.020 |
Why?
|
| Endotoxins | 1 | 2007 | 36 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 1179 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 700 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2887 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 417 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1929 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 1492 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19272 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 26173 | 0.010 |
Why?
|